UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aerobic and Resistance Exercise Improves Shoulder Function in Women Who Are Overweight or Obese and Have Breast Cancer: A Randomized Controlled Trial

Physical therapy, 2019-10, Vol.99 (10), p.1334-1345

2019

Volltextzugriff (PDF)

Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Clinical cancer research, 2007-01, Vol.13 (2), p.654-658

2007

Volltextzugriff (PDF)

Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone

BioMed research international, 2015-01, Vol.2015 (2015), p.1-9

2015

Volltextzugriff (PDF)

Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast

Breast cancer research and treatment, 2009-11, Vol.118 (1), p.161-168

2009

Volltextzugriff (PDF)

Reversal of Gonadotropin-releasing Hormone Agonist Induced Reductions in Mammographic Densities on Stopping Treatment

Cancer epidemiology, biomarkers & prevention, 2001-11, Vol.10 (11), p.1117-1120

2001

Volltextzugriff (PDF)

Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation

Breast cancer research and treatment, 2012-04, Vol.132 (2), p.653-660

2012

Volltextzugriff (PDF)

Decreasing time to initiation of inpatient chemotherapy at LAC+USC medical center utilizing an admission checklist

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.262-262

2019

Volltextzugriff (PDF)

Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk

Epidemiologic reviews, 1993, Vol.15 (1), p.17-30

1993

Volltextzugriff (PDF)

Mammographic Density Changes During the Menstrual Cycle

Cancer epidemiology, biomarkers & prevention, 2001-02, Vol.10 (2), p.141-142

2001

Volltextzugriff (PDF)

Utilization of a multisite financial reimbursement program to promote racial/ethnic diversity and inclusion in therapeutic cancer clinical trials: The iMPACT Study

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.85-85

2020

Volltextzugriff (PDF)

Is there a role for 21-gene recurrence score in mucinous carcinoma of breast?

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e12538-e12538

2018

Volltextzugriff (PDF)

Phase II trial of metronomic capecitabine and cyclophosphamide with lapatinib and trastuzumab in patients with HER2-positive metastatic breast cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e12508-e12508

2019

Volltextzugriff (PDF)

Changes in Mammographic Densities Induced by a Hormonal Contraceptive Designed to Reduce Breast Cancer Risk

JNCI : Journal of the National Cancer Institute, 1994-03, Vol.86 (6), p.431-436

1994

Volltextzugriff (PDF)

Review of next generation sequencing outcomes in patients with metastatic breast cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12558-e12558

2017

Volltextzugriff (PDF)

Abstract 3262: Biomarkers of response to deslorelin in women at high risk of breast cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3262-3262

2018

Volltextzugriff (PDF)

Circulating tumor cells and genomic profiling of patients with ERBB2 mutant, HER2 non-amplified metastatic breast cancer treated with neratinib

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12554-e12554

2017

Volltextzugriff (PDF)

Can Mammographic Densities Predict Effects of Tamoxifen on the Breast?

JNCI : Journal of the National Cancer Institute, 1996-01, Vol.88 (2), p.128-129

1996

Volltextzugriff (PDF)

Efficacy of low-dose capecitabine in metastatic breast cancer

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.1065-1065

2012

Volltextzugriff (PDF)

Soy Isoflavones for Breast Cancer Risk Reduction—Letter

Cancer prevention research (Philadelphia, Pa.), 2012-07, Vol.5 (7), p.984-985

2012

Volltextzugriff (PDF)

Value of routine staging imaging studies (RSIS) for patients with stage III breast cancer (BC)

Journal of clinical oncology, 2014-09, Vol.32 (26_suppl), p.122-122

2014

Volltextzugriff (PDF)

Soy isoflavones for breast cancer risk reduction

Cancer prevention research (Philadelphia, Pa.), 2012-07, Vol.5 (7), p.984-5; author reply 986-7

2012

Volltextzugriff (PDF)

The detection of changes in mammographic densities

Cancer epidemiology, biomarkers & prevention, 1998-01, Vol.7 (1), p.43-47

1998

Volltextzugriff (PDF)

Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics

Cancer research (Chicago, Ill.), 1988-01, Vol.48 (2), p.459-461

1988

Volltextzugriff (PDF)

Future possibilities in the prevention of breast cancer: luteinizing hormone-releasing hormone agonists

Breast cancer research : BCR, 2000-01, Vol.2 (4), p.264-267, Article 264

2000

Volltextzugriff (PDF)

The Endocrine Prevention of Breast Cancer

Cancer investigation, 1995, Vol.13 (5), p.495-504

1995

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

Humans
(22)
Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Female
(21)
Oncology
(18)
Adult
(13)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Breast Neoplasms - Prevention & Control
(11)
Middle Aged
(10)
Breast Cancer
(9)
Pharmacology. Drug Treatments
(7)
Antineoplastic Agents
(6)
Gynecology. Andrology. Obstetrics
(6)
Mammary Gland Diseases
(6)
Tumors
(6)
Mammography
(5)
Breast Neoplasms - Diagnostic Imaging
(4)
Breast Neoplasms - Epidemiology
(4)
Cell Division
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aerobic and Resistance Exercise Improves Shoulder Function in Women Who Are Overweight or Obese and Have Breast Cancer: A Randomized Controlled Trial

Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone

Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast

Reversal of Gonadotropin-releasing Hormone Agonist Induced Reductions in Mammographic Densities on Stopping Treatment

Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation

Decreasing time to initiation of inpatient chemotherapy at LAC+USC medical center utilizing an admission checklist

Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk

Mammographic Density Changes During the Menstrual Cycle

Utilization of a multisite financial reimbursement program to promote racial/ethnic diversity and inclusion in therapeutic cancer clinical trials: The iMPACT Study

Is there a role for 21-gene recurrence score in mucinous carcinoma of breast?

Phase II trial of metronomic capecitabine and cyclophosphamide with lapatinib and trastuzumab in patients with HER2-positive metastatic breast cancer

Changes in Mammographic Densities Induced by a Hormonal Contraceptive Designed to Reduce Breast Cancer Risk

Review of next generation sequencing outcomes in patients with metastatic breast cancer

Abstract 3262: Biomarkers of response to deslorelin in women at high risk of breast cancer

Circulating tumor cells and genomic profiling of patients with ERBB2 mutant, HER2 non-amplified metastatic breast cancer treated with neratinib

Can Mammographic Densities Predict Effects of Tamoxifen on the Breast?

Efficacy of low-dose capecitabine in metastatic breast cancer

Soy Isoflavones for Breast Cancer Risk Reduction—Letter

Value of routine staging imaging studies (RSIS) for patients with stage III breast cancer (BC)

Soy isoflavones for breast cancer risk reduction

The detection of changes in mammographic densities

Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics

Future possibilities in the prevention of breast cancer: luteinizing hormone-releasing hormone agonists

The Endocrine Prevention of Breast Cancer

Aktive Filter

Suchergebnisse filtern